Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Karen Schreiber; Savino Sciascia; Ian N. Bruce; Ian Giles; Maria J. Cuadrado; Hannah Cohen; Caroline Gordon; David Isenberg; S. ren Jacobsen; Saskia Middeldorp; Marta Mosca; Sue Pavord; Massimo Radin; Dario Roccatello; Jane Salmon; Evélyne Vinet; Anne Voss; Linda Watkins; Beverley J. Hunt

doi:https://doi.org/10.1016/S2665-9913(20)30382-9

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Karen Schreiber, Savino Sciascia, Ian N. Bruce, Ian Giles, Maria J. Cuadrado, Hannah Cohen, Caroline Gordon, David Isenberg, S. ren Jacobsen, Saskia Middeldorp, Marta Mosca, Sue Pavord, Massimo Radin, Dario Roccatello, Jane Salmon, Evélyne Vinet, Anne Voss, Linda Watkins, Beverley J. Hunt

Research output: Contribution to journal › Comment/Letter to the editor › Academic

4 Citations (Scopus)

Original language	English
Pages (from-to)	e735-e736
Journal	The Lancet Rheumatology
Volume	2
Issue number	12
Early online date	2020
DOIs	https://doi.org/10.1016/S2665-9913(20)30382-9
Publication status	Published - Dec 2020

Access to Document

https://doi.org/10.1016/S2665-9913(20)30382-9

Cite this

Schreiber, K., Sciascia, S., Bruce, I. N., Giles, I., Cuadrado, M. J., Cohen, H., Gordon, C., Isenberg, D., Jacobsen, S. R., Middeldorp, S., Mosca, M., Pavord, S., Radin, M., Roccatello, D., Salmon, J., Vinet, E., Voss, A., Watkins, L., & Hunt, B. J. (2020). Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians. The Lancet Rheumatology, 2(12), e735-e736. https://doi.org/10.1016/S2665-9913(20)30382-9

@article{09be3316dd03405585561221af97304b,

title = "Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians",

author = "Karen Schreiber and Savino Sciascia and Bruce, {Ian N.} and Ian Giles and Cuadrado, {Maria J.} and Hannah Cohen and Caroline Gordon and David Isenberg and Jacobsen, {S. ren} and Saskia Middeldorp and Marta Mosca and Sue Pavord and Massimo Radin and Dario Roccatello and Jane Salmon and Ev{\'e}lyne Vinet and Anne Voss and Linda Watkins and Hunt, {Beverley J.}",

year = "2020",

month = dec,

doi = "https://doi.org/10.1016/S2665-9913(20)30382-9",

language = "English",

volume = "2",

pages = "e735--e736",

journal = "The Lancet Rheumatology",

issn = "2665-9913",

publisher = "Lancet Publishing Group",

number = "12",

}

Schreiber, K, Sciascia, S, Bruce, IN, Giles, I, Cuadrado, MJ, Cohen, H, Gordon, C, Isenberg, D, Jacobsen, SR, Middeldorp, S, Mosca, M, Pavord, S, Radin, M, Roccatello, D, Salmon, J, Vinet, E, Voss, A, Watkins, L & Hunt, BJ 2020, 'Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians', The Lancet Rheumatology, vol. 2, no. 12, pp. e735-e736. https://doi.org/10.1016/S2665-9913(20)30382-9

TY - JOUR

T1 - Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

AU - Schreiber, Karen

AU - Sciascia, Savino

AU - Bruce, Ian N.

AU - Giles, Ian

AU - Cuadrado, Maria J.

AU - Cohen, Hannah

AU - Gordon, Caroline

AU - Isenberg, David

AU - Jacobsen, S. ren

AU - Middeldorp, Saskia

AU - Mosca, Marta

AU - Pavord, Sue

AU - Radin, Massimo

AU - Roccatello, Dario

AU - Salmon, Jane

AU - Vinet, Evélyne

AU - Voss, Anne

AU - Watkins, Linda

AU - Hunt, Beverley J.

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85097057985&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/S2665-9913(20)30382-9

DO - https://doi.org/10.1016/S2665-9913(20)30382-9

M3 - Comment/Letter to the editor

SN - 2665-9913

VL - 2

SP - e735-e736

JO - The Lancet Rheumatology

JF - The Lancet Rheumatology

IS - 12

ER -

Hydroxychloroquine in patients with rheumatic diseases during the COVID-19 pandemic: a letter to clinicians

Access to Document

Other files and links

Cite this